Valuation : Cogstate Limited

Market Cap 511M 366M 315M 298M 271M 506M 34.93B 3.54B 1.36B 17.8B 1.37B 1.34B 56.55B P/E 2027 *
24x
P/E 2028 * 19.6x
Enterprise Value 450M 322M 277M 262M 238M 445M 30.71B 3.11B 1.2B 15.65B 1.21B 1.18B 49.71B EV / Sales 2027 *
4.2x
EV / Sales 2028 * 3.57x
Free-Float
56.23%
Yield 2027 *
1.75%
Yield 2028 * 2.12%
1 day-2.90%
1 week-2.27%
Current month-2.27%
1 month+16.22%
3 months+16.22%
6 months+36.82%
Current year+33.19%
1 week 2.95
Extreme 2.95
3.15
1 month 2.62
Extreme 2.62
3.23
Current year 2.01
Extreme 2.01
3.23
1 year 1.75
Extreme 1.75
3.23
3 years 0.8
Extreme 0.795
3.23
5 years 0.8
Extreme 0.795
3.23
10 years 0.16
Extreme 0.155
3.23
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer - 1999-12-16
Chief Executive Officer - 2005-11-30
Director of Finance/CFO - 2021-01-31
Director TitleAgeSince
Director/Board Member - 2011-02-28
Chairman 67 2009-11-02
Director/Board Member - 2017-01-19
Date Insider Type Main position Quantity % Market Cap. Importance
5/20/26 Buy

Director

3,600 0.0021%
5/20/26 Buy

Director

430 0.0003%
4/15/26
Myer & Myer Pty Ltd.
SellCompany 9,974,569 5.8334%
Change 5-day change 1-year change 3-year change Capi.($)
-2.90%-2.27%+70.06%+102.69% 380M
-0.56%-8.30%-5.88%+10.58% 46.38B
-2.08%-2.81%+396.70%+533.09% 44.51B
+0.12%-2.48%+35.68%+20.50% 42.3B
-2.62%-5.52%-2.66%+77.44% 39.91B
-1.26%-2.95%+12.00%+40.55% 32.79B
+0.16%-2.27% - - 17.13B
-0.54%-1.66%+20.09%+115.10% 16.36B
-0.03%-2.56%+10.88%+30.90% 14.31B
-1.92%-6.43%+73.47%+36.68% 13.29B
Average -1.16%-2.70%+67.82%+107.50% 26.74B
Weighted average by Cap. -1.09%-3.25%+82.60%+129.32%

Financials

2027 *2028 *
Net sales 107M 76.62M 65.98M 62.31M 56.66M 106M 7.31B 741M 285M 3.73B 288M 281M 11.84B 122M 87.3M 75.17M 70.99M 64.55M 121M 8.33B 844M 325M 4.25B 328M 321M 13.49B
Net income 21.71M 15.54M 13.38M 12.64M 11.49M 21.49M 1.48B 150M 57.89M 756M 58.34M 57.06M 2.4B 26.49M 18.96M 16.33M 15.42M 14.02M 26.23M 1.81B 183M 70.64M 922M 71.19M 69.63M 2.93B
Net Debt -61.87M -44.28M -38.13M -36.01M -32.74M -61.25M -4.23B -428M -165M -2.15B -166M -163M -6.84B -75.6M -54.11M -46.59M -44M -40.01M -74.84M -5.16B -523M -202M -2.63B -203M -199M -8.36B
Logo Cogstate Limited
Cogstate Limited is a neuroscience technology company optimizing brain health assessments to advance the development of new medicines and to enable earlier clinical insights in healthcare. Its principal activities are the creation, validation, and commercialization of digital brain health assessments; and design and provision of quality assurance services in clinical trials, focused on the administration, scoring, and recording of conventional brain health assessments. Its segments include Clinical Trials, Healthcare, and Administration. In the Clinical Trials segment, the technology and associated services are used to quantify the effect of disease and of drugs, devices or other interventions on human subjects participating in clinical trials primarily conducted by pharmaceutical, and biotechnology companies. In the Healthcare segment, the technology and associated services are being developed as a tool for primary care physicians and/or hospitals to assess cognitive decline.
Employees
160
Date Price Change Volume
26-09-10 A$3.010 -2.90% 182,365
26-09-09 A$3.100 +1.64% 436,334
26-09-08 A$3.050 +1.67% 648,703
26-09-07 A$3.000 -2.91% 198,402
26-09-04 A$3.090 +0.65% 153,974
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
3.010AUD
Average target price
3.570AUD
Spread / Average Target
+18.60%

Quarterly revenue - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!